Stacey Goodman MD
Professor, Medicine, Vanderbilt University School of Medicine
Join to view full profile
3601 21st Ave SNashville, TN 37232
Phone+1 615-322-3000
Dr. Goodman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1992 - 1993- Vanderbilt University Medical CenterResidency, Internal Medicine, 1987 - 1990
New York University School of MedicineClass of 1987
Certifications & Licensure
TN State Medical License 1993 - 2023
AL State Medical License 2020 - 2020
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification StarPanel, Vanderbilt University, 2013, 2015, 2017
- CMS Meaningful Use Stage 1 Certification StarPanel, Vanderbilt University, 2013, 2015, 2017
- CMS Meaningful Use Stage 2 Certification StarPanel, Vanderbilt University, 2013, 2015, 2017
Clinical Trials
- Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) Start of enrollment: 2003 Dec 01
- Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) Start of enrollment: 2004 Aug 01
- Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) Start of enrollment: 2005 Dec 01
Publications & Presentations
PubMed
- 421 citationsDaratumumab-Based Treatment for Immunoglobulin Light-Chain AmyloidosisEfstathios Kastritis, Giovanni Palladini, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard
The New England Journal of Medicine. 2021-06-30 - 14 citationsBortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardle...Robert F. Cornell, Raphael Fraser, Luciano J. Costa, Stacey Goodman, Noel Estrada-Merly
Transplantation and Cellular Therapy. 2021-03-01 - Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Tran...Dilan A Patel, Karina A. Mendoza, Heidi Chen, Brian G. Engelhardt, Bipin N. Savani
Journal of Hematology. 2021-02-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
